Nanostring
Acquired2 known investors
NanoString (part of Bruker Spatial Biology) develops instruments and assays for spatial biology and gene expression analysis, including single-cell and subcellular spatial transcriptomics, proteomics, and multiomics. Its systems serve researchers in oncology, biomarker discovery, neuroscience, and translational and clinical research.
Investors · 2
Competitors · 2
by search overlapOup15 shared keywordsOxford University Press (OUP) provides dictionary data, language datasets, and lexical content in over 60 languages to power digital literacy tools, educational software, gaming platforms, and media experiences. The company works across reading apps, word games, quiz shows, and broadcast media to expand access to language learning and comprehension.
IDbyDNA13 shared keywordsScalable, high throughput DNA sequencing platforms.
Companies competing with Nanostring for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Nanostring do?
- NanoString (part of Bruker Spatial Biology) develops instruments and assays for spatial biology and gene expression analysis, including single-cell and subcellular spatial transcriptomics, proteomics, and multiomics. Its systems serve researchers in oncology, biomarker discovery, neuroscience, and translational and clinical research.
- Who are Nanostring's investors?
- Nanostring's investors include Aspect Ventures, Owl Capital.

